Fluid Biotech Revenue and Competitors
Estimated Revenue & Valuation
- Fluid Biotech's estimated annual revenue is currently $3.6M per year.
- Fluid Biotech's estimated revenue per employee is $155,000
Employee Data
- Fluid Biotech has 23 Employees.
- Fluid Biotech grew their employee count by 28% last year.
Fluid Biotech's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Operations | Reveal Email/Phone |
2 | VP, Business Development | Reveal Email/Phone |
3 | Senior Quality Engineer | Reveal Email/Phone |
4 | Quality Coordinator | Reveal Email/Phone |
Fluid Biotech Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $3.6M | 46 | 7% | $1.7M | N/A |
#3 | $2.5M | 32 | 14% | N/A | N/A |
#4 | $3.4M | 44 | -4% | N/A | N/A |
#5 | $11.8M | 76 | 41% | N/A | N/A |
#6 | $3.6M | 23 | -4% | N/A | N/A |
#7 | $1.2M | 16 | 0% | N/A | N/A |
#8 | $4.5M | 29 | -9% | N/A | N/A |
#9 | $3.1M | 20 | 33% | N/A | N/A |
#10 | $0.7M | 9 | -25% | N/A | N/A |
What Is Fluid Biotech?
Fluid Biotech is a start-up located in Calgary, Alberta. The company is developing an innovative brain stent to heal aneurysms. It represents years of research work from the laboratories at the University of Calgary.
keywords:N/AN/A
Total Funding
23
Number of Employees
$3.6M
Revenue (est)
28%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Fluid Biotech News
Cellmax Life; Burning Rock Biotech; Berry Genomics Co; HaploX Biotechnology Co; New Horizon Health Limited; Genetronhealth; Amoy Diagnostics Co...
Instant Oral Fluid Testing Devices Market Size 2022-2029| Key Players Abbott Laboratories, AccuBioTech, Guangzhou Wondfo Biotech, MEDACX Ltd.
Insight CXR Triage analyzes scans for presuspected conditions, such as a critical build-up of fluid or a collapsed lung. It then alerts clinicians of urgent...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 23 | -15% | N/A |
#2 | $2.3M | 23 | -4% | N/A |
#3 | $3M | 24 | 4% | N/A |
#4 | N/A | 24 | 50% | N/A |
#5 | $5.5M | 24 | -14% | N/A |